Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-10-27
2000-03-28
Chang, Ceila
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514212, 5142305, 514320, 514375, 514456, 540596, 544105, 546196, 548235, 548525, 549389, 549406, A61K 3140, C07D40510
Patent
active
060432691
ABSTRACT:
The present invention relates to therapeutically active compounds of formula I ##STR1## a method of preparing the same and to pharmaceutical compositions comprising the compounds. The novel compounds are useful in the prevention or treatment of estrogen related diseases or syndromes.
REFERENCES:
patent: 3340276 (1967-09-01), Carney et al.
patent: 3535344 (1970-10-01), Irmscher et al.
patent: 5254568 (1993-10-01), Kapril
patent: 5389646 (1995-02-01), Labroo
patent: 5395842 (1995-03-01), Labrie
patent: 5693646 (1997-12-01), Jones
Salman et al., J. Med. Chem., 26, pp. 592-595, (1983).
Bundgaard "Design of prodrugs" Elsevier, p. 3-9, 1985.
Durani et al. "a possible basis for structure-fuction relationship of estrogens" CA 95:109086, 1981.
Bury Paul Stanley
Christiansen Lise Brown
Jacobsen Poul
Kanstrup Anders
Treppendahl Svend
Chang Ceila
Novo Nordisk A S
Rozek Carole E.
Zelson Steve T.
LandOfFree
cis-3,4-chroman derivatives useful in the prevention or treatmen does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with cis-3,4-chroman derivatives useful in the prevention or treatmen, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and cis-3,4-chroman derivatives useful in the prevention or treatmen will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1326396